Remove Companies Remove Marketing Remove Pricing
article thumbnail

What Does the Post Crash VC Market Look Like?

Both Sides of the Table

Should SaaS companies trade at a 24x Enterprise Value (EV) to Next Twelve Month (NTM) Revenue multiple as they did in November 2021? This happens slowly because while public markets trade daily and prices then adjust instantly, private markets don’t get reset until follow-on financing rounds happen which can take 6–24 months.

article thumbnail

GoodRx Prices IPO

socalTECH

Santa Monica-based prescription and healthcare marketplace operator GoodRx has priced its IPO, saying late last night that it is offering up 34,615,384 shares of its Class A common stock at $33.00 The company priced well above its initial offering range, which was $24.00 Seelaus & Co., LLC and Ramirez & Co.,

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

8 Creative Pricing Strategies Most Startups Overlook

Startup Professionals Musings

As an advisor to new business owners, I’m accustomed to seeing primarily the simple traditional product pricing strategies , usually driven by competitor prices, or cost plus a reasonable margin. I often wonder whether you as the entrepreneur have worked as hard on your pricing strategy as you have on your innovative solution.

Pricing 145
article thumbnail

Can you defend your pricing niche against your competition?

Berkonomics

This week, we continue our series on marketing and positioning. There can be nothing more important in your business planning that selecting the proper pricing niche, making your story clear using that niche, and the defending your position against the competition. They are: Price. The danger of competing on price.

Pricing 226
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 per share, raising just over $1 billion for the company. The company will begin trading this morning on the Nasdaq Global Select Market as TSP.

Pricing 113
article thumbnail

Avidity Biosciences Prices IPO

socalTECH

San Diego-based Avidity Bio , a biopharmaceuticals company working on oligonucleotide-based therapies, priced its IPO last night, saying that it will offer up 14,400,000 shares of its common stock at $18.00 The company priced above its initial estimated offering range of $14.00 READ MORE>>.

Pricing 113
article thumbnail

How long can Zuckerberg afford to bankroll the AR/VR market?

TechCrunch LA

Last week, we talked about about the “de-stonkifying” of the market. The company’s stock tanked by more than 26 percent, representing a $230 billion reduction in market cap and a $31 billion drop in Zuckerberg’s personal net worth. Hello friends, and welcome back to Week in Review !

Marketing 246